Interference with Plasmodium metal metabolism by the quinolines and artemisinins is a proven chemotherapeutic target. Despite great progress, the precise molecular process of heme crystal formation, the target of the quinolines, is not understood. Global metabolic consequences of targeted interventions to Plasmodium metal biology have not been defined. The broad long term objective is to further define the molecular process of heme crystal formation biology that the quinolines target and to develop Plasmodium metabolic profiling as a method of drug target validation focused at first on metal related metabolism.
The specific aims for heme crystal formation are to compare heme crystal formation and inhibition initiated with subcellular parasite fractionations, in vitro lipid or protein formulations. The metabolic profiling specific aims are to identify common and unique metabolites of the uninfected erythrocyte compared to the infected erythrocyte that also respond to antimalarial drugs directed at metals and to analyze the altered Plasmodium metabolic profile in drug-resistant strains. The techniques of Scanning Electron Microscopy, Plasmodium culture and subcellular fractionation, and mass spectroscopic analysis will be used to achieve these aims. ? The significance of detailing heme crystal formation relates to fundamental knowledge of quinoline drug action and resistance. Plasmodium metabolic profiling will complement current transcriptome and proteomic analysis of drug target validation as part of the NIH """"""""roadmap"""""""" to study metabolic process components and networks in cells. Plasmodium parasitism provides a comparison of """"""""simple"""""""" erythrocyte cell to more complex infected cell. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI045774-07
Application #
7218672
Study Section
Pathogenic Eukaryotes Study Section (PTHE)
Program Officer
Rogers, Martin J
Project Start
1999-06-01
Project End
2010-03-31
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
7
Fiscal Year
2007
Total Cost
$314,216
Indirect Cost
Name
Johns Hopkins University
Department
Microbiology/Immun/Virology
Type
Schools of Public Health
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Pisciotta, John M; Scholl, Peter F; Shuman, Joel L et al. (2017) Quantitative characterization of hemozoin in Plasmodium berghei and vivax. Int J Parasitol Drugs Drug Resist 7:110-119
Mittler, Ron; Vanderauwera, Sandy; Suzuki, Nobuhiro et al. (2011) ROS signaling: the new wave? Trends Plant Sci 16:300-9
Coppens, Isabelle; Sullivan, David J; Prigge, Sean T (2010) An update on the rapid advances in malaria parasite cell biology. Trends Parasitol 26:305-10
Armenta, Jenny M; Cortes, Diego F; Pisciotta, John M et al. (2010) Sensitive and rapid method for amino acid quantitation in malaria biological samples using AccQ.Tag ultra performance liquid chromatography-electrospray ionization-MS/MS with multiple reaction monitoring. Anal Chem 82:548-58
Guiguemde, W Armand; Shelat, Anang A; Bouck, David et al. (2010) Chemical genetics of Plasmodium falciparum. Nature 465:311-5
Sullivan, David (2010) Uncertainty in mapping malaria epidemiology: implications for control. Epidemiol Rev 32:175-87
Pisciotta, John M; Sullivan, David (2008) Hemozoin: oil versus water. Parasitol Int 57:89-96
Shulaev, Vladimir; Cortes, Diego; Miller, Gad et al. (2008) Metabolomics for plant stress response. Physiol Plant 132:199-208
Bajad, Sunil; Shulaev, Vladimir (2007) Highly-parallel metabolomics approaches using LC-MS for pharmaceutical and environmental analysis. Trends Analyt Chem 26:625-636
Pisciotta, John M; Coppens, Isabelle; Tripathi, Abhai K et al. (2007) The role of neutral lipid nanospheres in Plasmodium falciparum haem crystallization. Biochem J 402:197-204

Showing the most recent 10 out of 18 publications